Caris Life Sciences, Inc. CAI
Set alert
32.10 USD 0.00 0.00%
At close
32.00 -0.10 -0.31%
Pre-market · Nov 3, 9:16 AM ET
Day range unavailable
14.19 52-week range 36.50
- YTD
- +18.98%
- 1 year
- +6.72%
- Open
- —
- Prev close
- 32.10
- Mkt cap
- 9.07B
- Vol
- 0
- Avg vol
- 4.83M
- EPS
- 1.69
- P/E
- 18.99
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 86.31
- Beta
- 0.00
- Short ratio
- 2.63
- Inst. own
- 57.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 29.16
- 200-d avg
- 21.58
- 1y target
- 32.46
Analyst view
Consensus: buy
Buy
Price target (mean) 32.46 +1.1% upside
Now 32.10
- Target (low)
- 22.00
- Target (mean)
- 32.46
- Target (high)
- 38.00
Ratings (0m) 14 10 buy · 4 hold · 0 sell
- Strong buy1
- Buy9
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.02012 | -0.00514 – 0.07 | 0.08 | -74.9% | 255.34M | +17.8% | 10 |
| Next quarter | 0.1122 | 0.05 – 0.19024 | 0.28 | -59.9% | 294.87M | +0.7% | 10 |
| Current year | 0.13801 | 0.04 – 0.26358 | -0.40721 | +133.9% | 1.03B | +26.8% | 11 |
| Next year | 0.37192 | 0.05 – 0.52178 | 0.13801 | +169.5% | 1.23B | +19.3% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 19, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Oct 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Initiated | — | Neutral |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 2, 2026 | BTIG | Reiterated | Buy | Buy |
| May 8, 2026 | Citigroup | Maintained | Buy | Buy |
| May 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 8, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 13, 2026 | Jefferies | Initiated | — | Buy |
| Apr 10, 2026 | Piper Sandler | Initiated | — | Neutral |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 13, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 27, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 27, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 17, 2026 | Baird | Initiated | — | Outperform |
| Dec 22, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Dec 2, 2025 | Canaccord Genuity | Initiated | — | Hold |
| Aug 13, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 13, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 13, 2025 | Citigroup | Maintained | Buy | Buy |
| Jul 15, 2025 | Evercore ISI Group | Initiated | — | Outperform |
| Jul 14, 2025 | TD Cowen | Initiated | — | Buy |
| Jul 14, 2025 | Guggenheim | Initiated | — | Buy |
| Jul 14, 2025 | Wolfe Research | Initiated | — | Outperform |